Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in:

Open Access 01-12-2024 | Review

The advance of single cell transcriptome to study kidney immune cells in diabetic kidney disease

Authors: Mengjia Wang, Fang Yao, Ning Chen, Ting Wu, Jiaxin Yan, Linshan Du, Shijie Zeng, Chunyang Du

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Diabetic kidney disease (DKD) is a prevalent microvascular complication of diabetes mellitus and a primary cause of end-stage renal disease (ESRD). Increasing studies suggest that immune cells are involved in regulating renal inflammation, which contributes to the progression of DKD. Compared with conventional methods, single-cell sequencing technology is more developed technique that has advantages in resolving cellular heterogeneity, parallel multi-omics studies, and discovering new cell types. ScRNA-seq helps researchers to analyze specifically gene expressions, signaling pathways, intercellular communication as well as their regulations in various immune cells of kidney biopsy and urine samples. It is still challenging to investigate the function of each cell type in the pathophysiology of kidney due to its complex and heterogeneous structure and function. Here, we discuss the application of single-cell transcriptomics in the field of DKD and highlight several recent studies that explore the important role of immune cells including macrophage, T cells, B cells etc. in DKD through scRNA-seq analyses. Through combing the researches of scRNA-seq on immune cells in DKD, this review provides novel perspectives on the pathogenesis and immune therapeutic strategy for DKD.
Literature
1.
2.
Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of Nephropathy in insulin-dependent diabetes Mellitus. N Engl J Med. 1994;330(1):15–8.PubMedCrossRef
3.
Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, et al. Decreasing incidence of severe Diabetic Microangiopathy in Type 1 diabetes. Diabetes Care. 2003;26(4):1258–64.PubMedCrossRef
4.
Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care. 2010;33(1):73–7.PubMedPubMedCentralCrossRef
5.
Zoccali C, Kramer A, Jager K. The databases: renal replacement therapy since 1989—The European Renal Association and European Dialysis and Transplant Association (ERA-EDTA). Clin J Am Soc Nephrol. 2009;4(1 Suppl):S18–22.PubMedCrossRef
6.
Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.PubMedCrossRef
7.
8.
Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of Diabetic kidney disease. N Engl J Med. 1989;320(18):1161–65.PubMedCrossRef
9.
Borch-Johnsen K, Nørgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, et al. Is diabetic nephropathy an inherited complication? Kidney Int. 1992;41(4):719–22.PubMedCrossRef
10.
Lee J, Tsogbadrakh B, Yang S, Ryu H, Kang E, Kang M, et al. Klotho ameliorates protection. Biochem Biophys Res Commun. 2021;534:1040–46.PubMedCrossRef
11.
Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, Group ftUS. Risk factors for renal dysfunction in type 2 diabetes. Diabetes. 2006;55(6):1832–39.PubMedCrossRef
12.
Hasan I, Brifkani Z, Heilig C, Nahman N, Atta M, Heilig K et al. Diabetic Nephropathy on Renal Biopsy in the absence of clinical diabetes Mellitus. Am J Kidney Dis. 2020;75(4):583.
13.
Li Y, Pan Y, Cao S, Sasaki K, Wang Y, Niu A, et al. Podocyte EGFR inhibits Autophagy through Upregulation of Rubicon in type 2 Diabetic Nephropathy. Diabetes. 2021;70(2):562–76.PubMedCrossRef
14.
Ma J, Li C, Liu T, Zhang L, Wen X, Liu X, et al. Identification of markers for diagnosis and treatment of Diabetic kidney Disease based on the ferroptosis and Immune. Oxid Med Cell Longev. 2022;2022:1–21.
15.
Kurts C, Panzer U, Anders H-J, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol. 2013;13(10):738–53.PubMedCrossRef
16.
Donnan MD, Kenig-Kozlovsky Y, Quaggin SE. The lymphatics in kidney health and disease. Nat Rev Nephrol. 2021;17(10):655–75.PubMedCrossRef
17.
Eberwine J, Sul J-Y, Bartfai T, Kim J. The promise of single-cell sequencing. Nat Methods. 2014;11(1):25–7.PubMedCrossRef
18.
19.
Tang F, Barbacioru C, Wang Y, Nordman E, Lee C, Xu N, et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat Methods. 2009;6(5):377–82.PubMedCrossRef
20.
Islam S, Kjällquist U, Moliner A, Zajac P, Fan J-B, Lönnerberg P, et al. Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq. Genome Res. 2011;21(7):1160–67.PubMedPubMedCentralCrossRef
21.
Ramsköld D, Luo S, Wang Y-C, Li R, Deng Q, Faridani OR, et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol. 2012;30(8):777–82.PubMedPubMedCentralCrossRef
22.
Macosko Evan Z, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, et al. Highly parallel genome-wide expression profiling of individual cells using Nanoliter droplets. Cell. 2015;161(5):1202–14.PubMedPubMedCentralCrossRef
23.
Gierahn TM, Wadsworth MH, Hughes TK, Bryson BD, Butler A, Satija R, et al. Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nat Methods. 2017;14(4):395–98.PubMedPubMedCentralCrossRef
24.
Asp M, Bergenstråhle J, Lundeberg J. Spatially resolved transcriptomes—Next Generation Tools for tissue exploration. BioEssays. 2020;42(10):1900221.CrossRef
25.
Liu C, Li R, Li Y, Lin X, Zhao K, Liu Q, et al. Spatiotemporal mapping of gene expression landscapes and developmental trajectories during zebrafish embryogenesis. Dev Cell. 2022;57(10):1284–e985.PubMedCrossRef
26.
Wang Y, Chen Y, Gao J, Xie H, Guo Y, Yang J, et al. Mapping crossover events of mouse meiotic recombination by restriction fragment ligation-based Refresh-Seq. Cell Discov. 2024;10(1):26.PubMedPubMedCentralCrossRef
27.
Isnard P, D Humphreys B. Spatial transcriptomics: integrating morphology and molecular mechanisms of kidney diseases. Am J Pathol. 2024. S0002-9440(24)00276-1.
28.
Muto Y, Wilson PC, Ledru N, Wu H, Dimke H, Waikar SS, et al. Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney. Nat Commun. 2021;12(1):2190.PubMedPubMedCentralCrossRef
29.
Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489(7416):391–99.PubMedPubMedCentralCrossRef
30.
Ziegenhain C, Vieth B, Parekh S, Reinius B, Guillaumet-Adkins A, Smets M, et al. Comparative analysis of single-cell RNA sequencing methods. Mol Cell. 2017;65(4):631–e434.PubMedCrossRef
31.
Zilionis R, Nainys J, Veres A, Savova V, Zemmour D, Klein AM, et al. Single-cell barcoding and sequencing using droplet microfluidics. Nat Protoc. 2017;12(1):44–73.PubMedCrossRef
32.
Dupont CL, Rusch DB, Yooseph S, Lombardo M-J, Alexander Richter R, Valas R, et al. Genomic insights to SAR86, an abundant and uncultivated marine bacterial lineage. ISME J. 2012;6(6):1186–99.PubMedCrossRef
33.
Aad G, Abbott B, Abbott DC, Abud AA, Abeling K, Abhayasinghe DK, et al. Measurements of jet observables sensitive to b-quark fragmentation in tt¯ events at the LHC with the ATLAS detector. Phys Rev D. 2022;106(3):032008.CrossRef
34.
Spadaccini R, Crescenzi O, Tancredi T, De Casamassimi N, Saviano G, Scognamiglio R, et al. Solution structure of a sweet protein: NMR study of MNEI, a single chain monellin. J Mol Biol. 2001;305(3):505–14.PubMedCrossRef
35.
Yilmaz S, Allgaier M, Hugenholtz P. Multiple displacement amplification compromises quantitative analysis of metagenomes. Nat Methods. 2010;7(12):943–44.PubMedCrossRef
36.
Picelli S, Björklund ÅK, Faridani OR, Sagasser S, Winberg G, Sandberg R. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods. 2013;10(11):1096–98.PubMedCrossRef
37.
Mao ZH, Gao ZX, Liu Y, Liu DW, Liu ZS, Wu P. Single-cell transcriptomics: a new tool for studying diabetic kidney disease. Front Physiol. 2023;13:1053850.PubMedPubMedCentralCrossRef
38.
Ong E, Wang LL, Schaub J, O’Toole JF, Steck B, Rosenberg AZ, et al. Modelling kidney disease using ontology: insights from the kidney Precision Medicine Project. Nat Rev Nephrol. 2020;16(11):686–96.PubMedPubMedCentralCrossRef
39.
Chen S, Lake BB, Zhang K. High-throughput sequencing of the transcriptome and chromatin accessibility in the same cell. Nat Biotechnol. 2019;37(12):1452–57.PubMedPubMedCentralCrossRef
40.
Pijuan-Sala B, Wilson NK, Xia J, Hou X, Hannah RL, Kinston S, et al. Single-cell chromatin accessibility maps reveal regulatory programs driving early mouse organogenesis. Nat Cell Biol. 2020;22(4):487–97.PubMedPubMedCentralCrossRef
41.
Wu H, Kirita Y, Donnelly EL, Humphreys BD. Advantages of single-nucleus over single-cell RNA sequencing of adult kidney: rare cell types and Novel Cell States revealed in fibrosis. J Am Soc Nephrol. 2019;30(1):23–32.PubMedCrossRef
42.
Guo J, Grow EJ, Yi C, Mlcochova H, Maher GJ, Lindskog C, et al. Chromatin and single-cell RNA-Seq profiling reveal Dynamic Signaling and metabolic transitions during human spermatogonial stem Cell Development. Cell Stem Cell. 2017;21(4):533–e466.PubMedPubMedCentralCrossRef
43.
Wang Q, Zhang Y, Zhang B, Fu Y, Zhao X, Zhang J, et al. Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma. Nat Commun. 2022;13(1):31.PubMedPubMedCentralCrossRef
44.
Gisch DL, Brennan M, Lake BB, Basta J, Keller MS, Ferreiraet RM, et al. The chromatin landscape of healthy and injured cell types in the human kidney. Nat Commun. 2024;15(1):433.PubMedPubMedCentralCrossRef
45.
Park J, Shrestha R, Qiu C, Kondo A, Huang S, Werth M, et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science. 2018;360(6390):758–63.PubMedPubMedCentralCrossRef
46.
Fu J, Akat KM, Sun Z, Zhang W, Schlondorff D, Liu Z, et al. Single-cell RNA profiling of glomerular cells shows dynamic changes in Experimental Diabetic kidney disease. J Am Soc Nephrol. 2019;30(4):533–45.PubMedPubMedCentralCrossRef
47.
Dumas SJ, Meta E, Borri M, Goveia J, Rohlenova K, Conchinha NV, et al. Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to Water Deprivation. J Am Soc Nephrol. 2020;31(1):118–38.PubMedCrossRef
48.
Chung J-J, Goldstein L, Chen Y-JJ, Lee J, Webster JD, Roose-Girma M, et al. Single-cell transcriptome profiling of the kidney Glomerulus identifies key cell types and reactions to Injury. J Am Soc Nephrol. 2020;31(10):2341–54.PubMedPubMedCentralCrossRef
49.
Braun DA, Street K, Burke KP, Cookmeyer DL, Denize T, Pedersen CB, et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell. 2021;39(5):632–e488.PubMedPubMedCentralCrossRef
50.
Krishna C, DiNatale RG, Kuo F, Srivastava RM, Vuong L, Chowell D, et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell. 2021;39(5):662–e776.PubMedPubMedCentralCrossRef
51.
Obradovic A, Chowdhury N, Haake SM, Ager C, Wang V, Vlahos L, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184(11):2988–e300516.PubMedPubMedCentralCrossRef
52.
He B, Chen P, Zambrano S, Dabaghie D, Hu Y, Möller-Hackbarth K, et al. Single-cell RNA sequencing reveals the mesangial identity and species diversity of glomerular cell transcriptomes. Nat Commun. 2021;12(1):2141.PubMedPubMedCentralCrossRef
53.
Pickering H, Sen S, Arakawa-Hoyt J, Ishiyama K, Sun Y, Parmar R, et al. NK and CD8 + T cell phenotypes predict onset and control of CMV viremia after kidney transplant. JCI Insight. 2021;6(21):e153175.PubMedPubMedCentralCrossRef
54.
Sheng X, Guan Y, Ma Z, Wu J, Liu H, Qiu C, et al. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments. Nat Genet. 2021;53(9):1322–33.PubMedPubMedCentralCrossRef
55.
Li H, Dixon EE, Wu H, Humphreys BD. Comprehensive single-cell transcriptional profiling defines shared and unique epithelial injury responses during kidney fibrosis. Cell Metab. 2022;34(12):1977–e989.PubMedPubMedCentralCrossRef
56.
Wu H, Gonzalez Villalobos R, Yao X, Reilly D, Chen T, Rankin M, et al. Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies. Cell Metab. 2022;34(7):1064–e786.PubMedPubMedCentralCrossRef
57.
Lu X, Li L, Suo L, Huang P, Wang H, Han S, et al. Single-cell RNA sequencing profiles identify important pathophysiologic factors in the Progression of Diabetic Nephropathy. Front Cell Dev Biol. 2022;10:798316.
58.
Li R, Ferdinand JR, Loudon KW, Bowyer GS, Laidlaw S, Muyas F, et al. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer. Cancer Cell. 2022;40(12):1583–e9910.PubMedPubMedCentralCrossRef
59.
Kong F, Ye S, Zhong Z, Zhou X, Zhou W, Liu Z, et al. Single-cell transcriptome analysis of chronic antibody-mediated rejection after renal transplantation. Front Immunol. 2022;12:767618.PubMedPubMedCentralCrossRef
60.
Rashmi P, Sur S, Sigdel TK, Boada P, Schroeder AW, Damm I, et al. Multiplexed droplet single-cell sequencing (Mux-Seq) of normal and transplant kidney. Am J Transpl. 2022;22(3):876–85.CrossRef
61.
Lake BB, Menon R, Winfree S, Hu Q, Ferreira RM, Kalhor K, et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature. 2023;619(7970):585–94.PubMedPubMedCentralCrossRef
62.
McDaniels JM, Shetty AC, Kuscu C, Kuscu C, Bardhi E, Rousselle T, et al. Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis. Kidney Int. 2023;103(6):1077–92.PubMedPubMedCentralCrossRef
63.
Wen N, Wu J, Li H, Liao J, Lan L, Yang X, et al. Immune landscape in rejection of renal transplantation revealed by high-throughput single-cell RNA sequencing. Front Cell Dev Biol. 2023;11:1208566.PubMedPubMedCentralCrossRef
64.
Leckie-Harre A, Silverman I, Wu H, Humphreys BD, Malone AF. Sequencing of physically interacting cells in human kidney allograft rejection to Infer Contact-dependent Immune cell transcription. Transplantation. 2024;108(2):421–29.PubMedPubMedCentral
65.
Lu J, Chen Y, Zhou K, Ling Y, Qin Q, Lu W, et al. Immune characteristics of kidney transplant recipients with acute respiratory distress syndrome induced by COVID-19 at single-cell resolution. Respir Res. 2024;25(1):34.PubMedPubMedCentralCrossRef
66.
Fu J, Sun Z, Wang X, Zhang T, Yuan W, Salem F, et al. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 2022;102(6):1291–304.PubMedPubMedCentralCrossRef
67.
Liu S, Zhao Y, Lu S, Zhang T, Lindenmeyer MT, Nair V, et al. Single-cell transcriptomics reveals a mechanosensitive injury signaling pathway in early diabetic nephropathy. Genome Med. 2023;15(1):2.PubMedPubMedCentralCrossRef
68.
Li Y, Lin H, Shu S, Sun Y, Lai W, Chen W, et al. Integrative transcriptome analysis reveals TEKT2 and PIAS2 involvement in diabetic nephropathy. FASEB J. 2022;36(11):e22592.PubMedCrossRef
69.
Tsai Y-C, Kuo M-C, Huang J-C, Chang W-A, Wu L-Y, Huang Y-C, et al. Single-cell transcriptomic profiles in the pathophysiology within the microenvironment of early diabetic kidney disease. Cell Death Dis. 2023;14(7):442.PubMedPubMedCentralCrossRef
70.
Balzer MS, Pavkovic M, Frederick J, Abedini A, Freyberger A, Vienenkötter J, et al. Treatment effects of soluble guanylate cyclase modulation on diabetic kidney disease at single-cell resolution. Cell Rep Med. 2023;4(4):100992.PubMedPubMedCentralCrossRef
71.
Menon R, Otto EA, Sealfon R, Nair V, Wong AK, Theesfeld CL, et al. SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease. Kidney Int. 2020;98(6):1502–18.PubMedPubMedCentralCrossRef
72.
Barwinska D, El-Achkar TM, Melo Ferreira R, Syed F, Cheng Y-H, Winfree S, et al. Molecular characterization of the human kidney interstitium in health and disease. Sci Adv. 2021;7(7):eabd3359.PubMedPubMedCentralCrossRef
73.
Stefansson VTN, Nair V, Melsom T, Looker HC, Mariani LH, Fermin D, et al. Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease. Kidney Int. 2022;102(6):1345–58.PubMedPubMedCentralCrossRef
74.
Wilson PC, Muto Y, Wu H, Karihaloo A, Waikar SS, Humphreys BD. Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression. Nat Commun. 2022;13(1):5253.PubMedPubMedCentralCrossRef
75.
Hirohama D, Abedini A, Moon S, Surapaneni A, Dillon ST, Vassalotti A, et al. Unbiased human kidney tissue Proteomics identifies Matrix Metalloproteinase 7 as a kidney Disease Biomarker. J Am Soc Nephrol. 2023;34(7):1279–91.PubMedPubMedCentralCrossRef
76.
Schaub JA, AlAkwaa FM, McCown PJ, Naik AS, Nair V, Eddy S, et al. SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes. J Clin Invest. 2023;133(5):e164486.PubMedPubMedCentralCrossRef
77.
Wu J, Sun Z, Yang S, Fu J, Fan Y, Wang N, et al. Kidney single-cell transcriptome profile reveals distinct response of proximal tubule cells to SGLT2i and ARB treatment in diabetic mice. Mol Ther. 2022;30(4):1741–53.PubMedCrossRef
78.
Sembach FE, Østergaard MV, Vrang N, et al. Rodent models of diabetic kidney disease: human translatability and preclinical validity. Drug Discov Today. 2021;26(1):200–17.PubMedCrossRef
79.
Sullivan T, Miao Z, Dairaghi DJ, Krasinski A, Wang Y, Zhao BN, et al. CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice. Am J Physiol Ren Physiol. 2013;305(9):F1288–97.CrossRef
80.
Zeeuw Dd, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, et al. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diab Endocrinol. 2015;3(9):687–96.
81.
Zeng H, Yang X, Luo S, Zhou Y. The advances of single-cell RNA-Seq in kidney immunology. Front Physiol. 2021;12:752679
82.
Stewart BJ, Ferdinand JR, Young MD, Mitchell TJ, Loudon KW, Riding AM, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365(6460):1461–66.PubMedPubMedCentralCrossRef
83.
Williams JW, Giannarelli C, Rahman A, Randolph GJ, Kovacic JC. Macrophage Biology, classification, and phenotype in Cardiovascular Disease. J Am Coll Cardiol. 2018;72(18):2166–80.PubMedPubMedCentralCrossRef
84.
You H, Gao T, Cooper TK, Brian Reeves W, Awad AS. Macrophages directly mediate diabetic renal injury. Am J Physiol Ren Physiol. 2013;305(12):F1719–27.CrossRef
85.
Tang PM-K, Nikolic-Paterson DJ, Lan H-Y. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144–58.PubMedCrossRef
86.
Wilson PC, Wu H, Kirita Y, Uchimura K, Ledru N, Rennke HG, et al. The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A. 2019;116(39):19619–25.PubMedPubMedCentralCrossRef
87.
Wu H, Dixon EE, Xuanyuan Q, Guo J, Yoshimura Y, Debashish C, et al. High resolution spatial profiling of kidney injury and repair using RNA hybridization-based in situ sequencing. Nat Commun. 2024;15(1):1396.PubMedPubMedCentralCrossRef
88.
Zhang C, Li H, Wang S. Common gene signatures and molecular mechanisms of diabetic nephropathy and metabolic syndrome. Front Public Health. 2023;11:1150122.PubMedPubMedCentralCrossRef
89.
Klessens CQF, Zandbergen M, Wolterbeek R, Bruijn JA, Rabelink TJ, Bajema IM, et al. Macrophages in diabetic nephropathy in patients with type 2 diabetes. Nephrol Dial Transpl. 2016;32(8):1322–29.
90.
Wu H, Humphreys BD. Immune cell heterogeneity in a mouse model of diabetic kidney disease. Kidney Int. 2022;102(6):1215–16.PubMedCrossRef
91.
Zhang X, Chao P, Zhang L, Xu L, Cui X, Wang S, et al. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. 2023;14:1030198.PubMedPubMedCentralCrossRef
92.
Li T, Shen K, Li J, Leung SWS, Zhu T, Shi Y. Glomerular endothelial cells are the coordinator in the Development of Diabetic Nephropathy. Front Med (Lausanne). 2021;8:655639.PubMedCrossRef
93.
Zheng Z, Zheng F. A complex auxiliary: IL-17/Th17 signaling during type 1 diabetes progression. Mol Immunol. 2019;105:16–31.PubMedCrossRef
94.
Yen H-R, Harris TJ, Wada S, Grosso JF, Getnet D, Goldberg MV, et al. Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol. 2009;183(11):7161–68.PubMedCrossRef
95.
Ciric B, El-behi M, Cabrera R, Zhang G-X, Rostami A. IL-23 drives pathogenic IL-17-Producing CD8 + T cells. J Immunol. 2009;182(9):5296–305.PubMedCrossRef
96.
Marwaha AK, Crome SQ, Panagiotopoulos C, Berg KB, Qin H, Ouyang Q, et al. Cutting Edge: increased IL-17–Secreting T cells in children with New-Onset type 1 diabetes. J Immunol. 2010;185(7):3814–18.PubMedCrossRef
97.
Chan AJ, Alikhan MA, Odobasic D, Gan PY, Khouri MB, Steinmetz OM, et al. Innate IL-17A–Producing leukocytes promote acute kidney Injury via Inflammasome and Toll-Like receptor activation. Am J Pathol. 2014;184(5):1411–18.PubMedCrossRef
98.
Krohn S, Nies JF, Kapffer S, Schmidt T, Riedel J-H, Kaffke A, et al. IL-17 C/IL-17 receptor E signaling in CD4 + T cells promotes TH17 cell-driven glomerular inflammation. J Am Soc Nephrol. 2018;29(4):1210–22.PubMedPubMedCentralCrossRef
99.
Koga T, Ichinose K, Tsokos GC. T cells and IL-17 in lupus nephritis. Clin Immunol. 2017;185:95–9.PubMedCrossRef
100.
Peng X, Xiao Z, Zhang J, Li Y, Dong Y, Du J. IL-17A produced by both γδ T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J Pathol. 2015;235(1):79–89.PubMedCrossRef
101.
Chen D, Shao M, Song Y, Ren G, Guo F, Fan X, et al. Single-cell RNA-seq with spatial transcriptomics to create an atlas of human diabetic kidney disease. FASEB J. 2023;37(6):e22938.PubMedCrossRef
102.
Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med. 2011;3(85):85ra46.
103.
Gregersen JW, Jayne DRW. B-cell depletion in the treatment of lupus nephritis. Nat Rev Nephrol. 2012;8(9):505–14.PubMedCrossRef
104.
Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, et al. Rituximab or Cyclosporine in the treatment of Membranous Nephropathy. N Engl J Med. 2019;381(1):36–46.PubMedCrossRef
105.
106.
Shen P, Fillatreau S. Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol. 2015;15(7):441–51.PubMedCrossRef
107.
Wei Y, Gao X, Li A, Liang M, Jiang Z. Single-nucleus transcriptomic analysis reveals important cell cross-talk in Diabetic kidney disease. Front Med (Lausanne). 2021;8:657956.PubMedCrossRef
108.
Tang SCW, Yiu WH. Innate immunity in diabetic kidney disease. Nat Rev Nephrol. 2020;16(4):206–22.PubMedCrossRef
109.
Xu M, Zhou H, Hu P, Pan Y, Wang S, Liu L, et al. Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning. Front Immunol. 2023;14:1084531.PubMedPubMedCentralCrossRef
110.
Zhang H, Hu J, Zhu J, Li Q, Fang L. Machine learning-based metabolism-related genes signature and immune infiltration landscape in diabetic nephropathy. Front Endocrinol (Lausanne). 2022;13:1026938.PubMedCrossRef
111.
Lu K, Wang L, Fu Y, Li G, Zhang X, Cao M. Bioinformatics analysis identifies immune-related gene signatures and subtypes in diabetic nephropathy. Front Endocrinol (Lausanne). 2022;13:1048139.PubMedCrossRef
112.
Kong L, Andrikopoulos S, MacIsaac RJ, Mackay LK, Nikolic-Paterson DJ, Torkamani N, et al. Role of the adaptive immune system in diabetic kidney disease. J Diabetes Investig. 2022;13(2):213–26.PubMedCrossRef
113.
Gupta A, Singh K, Fatima S, Ambreen S, Zimmermann S, Younis R, et al. Neutrophil Extracellular traps promote NLRP3 inflammasome activation and glomerular endothelial dysfunction in Diabetic kidney disease. Nutrients. 2022;14(14):2965.PubMedPubMedCentralCrossRef
114.
Guo W, Song Y, Sun Y, Du H, Cai Y, You Q, et al. Systemic immune-inflammation index is associated with diabetic kidney disease in type 2 diabetes mellitus patients: evidence from NHANES 2011–2018. Front Endocrinol (Lausanne). 2022;13:1071465.PubMedCrossRef
115.
Zhang N, Zheng Q, Wang Y, Lin J, Wang H, Liu R, et al. Renoprotective Effect of the recombinant Anti-IL-6R Fusion proteins by inhibiting JAK2/STAT3 signaling pathway in Diabetic Nephropathy. Front Pharmacol. 2021;12:681424.PubMedPubMedCentralCrossRef
116.
Zhang F, Wang C, Wen X, Chen Y, Mao R, Cui D, et al. Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103 + DCs-mediated CD8 + T cell responses. J Cell Mol Med. 2020;24(10):5817–31.PubMedPubMedCentralCrossRef
117.
Yuan Y, Li L, Zhu L, Liu F, Tang X, Liao G, et al. Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy. Stem Cells. 2020;38(5):639–52.PubMedCrossRef
118.
Ding J, Adiconis X, Simmons SK, Kowalczyk MS, Hession CC, Marjanovic ND, et al. Systematic comparison of single-cell and single-nucleus RNA-sequencing methods. Nat Biotechnol. 2020;38(6):737–46.PubMedPubMedCentralCrossRef
119.
Hagemann-Jensen M, Ziegenhain C, Chen P, Ramsköld D, Hendriks G-J, Larsson AJM, et al. Single-cell RNA counting at allele and isoform resolution using Smart-seq3. Nat Biotechnol. 2020;38(6):708–14.PubMedCrossRef
120.
Kharchenko PV. The triumphs and limitations of computational methods for scRNA-seq. Nat Methods. 2021;18(7):723–32.PubMedCrossRef
121.
Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature. 2016;532(7600):512–16.PubMedPubMedCentralCrossRef
122.
123.
Adam M, Potter AS, Potter SS. Psychrophilic proteases dramatically reduce single cell RNA-seq artifacts: a molecular atlas of kidney development. Development. 2017;144(19):3625–32.PubMedPubMedCentral
Metadata
Title
The advance of single cell transcriptome to study kidney immune cells in diabetic kidney disease
Authors
Mengjia Wang
Fang Yao
Ning Chen
Ting Wu
Jiaxin Yan
Linshan Du
Shijie Zeng
Chunyang Du
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03853-y

Other articles of this Issue 1/2024

The causal relationship between COVID-19 and estimated glomerular filtration rate: a bidirectional Mendelian randomization study

Anuria after kidney transplantation diagnosed as early recurrence of focal segmental glomerulosclerosis combined with acute calcineurin inhibitor nephrotoxicity: a case report and literature review

Autonomic neuropathy in dialysis patients – investigations with a new symptom score (COMPASS 31)

  • Open Access
  • Research

Pharmacist-driven outreach initiative to increase prescribing of sodium-glucose cotransporter-2 inhibitors in eligible VHA patients with chronic kidney disease: a study protocol

Medication non-adherence and its associated factors among kidney transplant patients in a large teaching hospital in Ethiopia

Validity and reliability of Persian version of Low Physical Activity Questionnaire (LoPAQ)

  • Open Access
  • Research

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits